查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495421

治疗诊断学市场：按产品、应用和最终用户 - 2024-2030 年全球预测

Theranostics Market by Product (Product, Services, Software), Application (Bone Metastatis, Cardiovascular Diseases, Lymphoma), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年治疗诊断学市场规模为23.3亿美元，预计2024年将达26.7亿美元，2030年将达61.8亿美元，复合年增长率为14.89%。

治疗诊断学代表了一个创新的医学领域，它将诊断与基于诊断测试结果的标靶治疗相结合。这种方法可以实现个人化治疗，透过根据个人的疾病特征量身定制治疗，从而实现更有效率、更有效的医疗保健服务。治疗诊断学的主要用途包括肿瘤学、心血管疾病、神经系统疾病和感染疾病。治疗诊断学的最终用户主要是医院和诊所、诊断实验室和研究机构，它们可以透过整合治疗和诊断过程来显着改善患者护理。由于全球目标疾病的盛行率不断增加，对治疗诊断学的需求也不断增加。个人化医疗的不断增长趋势和分子生物学的进步正在扩大治疗诊断学的使用。此外，医疗保健基础设施的成长和全球研发活动投资的增加是治疗诊断学市场成长的主要驱动力。与研发相关的高成本、与资料隐私相关的问题以及个人化医疗的伦理考量对市场成长构成了重大挑战。新生物标记、非侵入性成像技术和精准治疗药物的开拓预计将带来市场成长机会。资料分析和机器学习的集合成为开发患者反应预测模型、优化治疗方法和监测疾病进展提供了前沿。

主要市场统计
基准年[2023] 23.3亿美元
预测年份 [2024] 26.7亿美元
预测年份 [2030] 61.8亿美元
复合年增长率（%） 14.89%

区域洞察

美洲是治疗诊断学市场开拓高度发展的地区，其特点是医疗保健支出高、专利註册力度大以及对个人化医疗的大量投资。人们对个人化医疗益处的认识不断提高，以及公共和私营部门对治疗诊断学研究和应用的投资不断增加，预计将在美洲建立市场基础。在欧盟（EU），监管支持以及强大的医疗保健系统正在推动治疗诊断学市场的成长。德国、法国和英国等国家处于前沿，其研究重点是癌症和神经退化性疾病。在医疗保健基础设施投资以及与西方生物技术公司合作的推动下，中东地区重新表达了兴趣。非洲在重点提供可及的诊断服务方面具有潜力，特别是在卫生系统发达的地区。在政府推动个人化医疗创新措施的推动下，亚太地区正迅速成为治疗诊断学的关键地区。随着日本人口老化，对先进治疗诊断解决方案的需求日益增长，特别是在癌症和心血管疾病方面。随着印度医疗保健产业的不断发展以及对平价医疗的重视，对社区治疗研究和合作研究的投资正在增加。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在治疗诊断学市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对治疗诊断学市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该领域竞争性质的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在治疗诊断学市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球目标疾病的盛行率正在增加
      • 个人化医疗与分子生物学的进展
    • 抑制因素
      • 研发成本高、监理核准复杂
    • 机会
      • 加强治疗诊断学中资料分析和机器学习的集成
      • 新生物标记和非侵入性成像技术的开发仍在继续
    • 任务
      • 资料隐私和个人化医疗的伦理考量
  • 市场区隔分析
    • 产品：更多地使用软体进行资料收集、处理和分析
    • 最终使用者：扩大医院治疗诊断学在各种疾病管理的潜力
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章治疗诊断学市场：副产品

  • 产品
  • 服务
  • 软体

第七章治疗诊断学市场：依应用分类

  • 骨转移
  • 心血管疾病
  • 淋巴瘤
  • 神经内分泌肿瘤
  • 摄护腺癌

第八章治疗诊断学市场：依最终使用者分类

  • 癌症护理中心
  • 医院
  • 研究学术中心
  • 治疗诊断学中心

第九章美洲治疗诊断学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太治疗治疗诊断学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的治疗诊断学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Clarity 的前列腺癌药物临床试验在最高剂量水平队列中取得进展
    • BAMF Health 和 GE Healthcare 合作，为治疗诊断学的发展提供永续、可扩展的解决方案
    • 加州大学洛杉矶分校健康中心开设治疗诊断学中心
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-61081604A0A5

[194 Pages Report] The Theranostics Market size was estimated at USD 2.33 billion in 2023 and expected to reach USD 2.67 billion in 2024, at a CAGR 14.89% to reach USD 6.18 billion by 2030.

Theranostics represents an innovative field in medical science that combines diagnostics with targeted therapy based on diagnostic test results. This approach enables personalized treatment, allowing for more efficient and effective healthcare delivery by tailoring treatment to the individual's specific disease characteristics. The primary applications of theranostics include oncology, cardiovascular diseases, neurological disorders, and infectious diseases, among others. The end-users of theranostics are largely hospitals and clinics, diagnostic laboratories, and research institutions, where the integration of therapeutic and diagnostic processes can significantly enhance patient care. The increasing prevalence of target diseases worldwide is expanding the need for theranostics. The growing inclination towards personalized medicines and rising advancements in molecular biology are expanding the usage of theranostics. Additionally, the growth of healthcare infrastructure and increasing investments in R&D activities globally serve as key drivers for the growth of the theranostics market. High costs associated with R&D and issues related to data privacy and the ethical considerations of personalized medicine pose significant challenges to market growth. Growing development of novel biomarkers, non-invasive imaging techniques, and precision therapeutics are expected to create opportunities for market growth. The integration of data analytics and machine learning presents a frontier for developing predictive models for patient response, optimizing treatment regimens, and monitoring disease progression.

KEY MARKET STATISTICS
Base Year [2023] USD 2.33 billion
Estimated Year [2024] USD 2.67 billion
Forecast Year [2030] USD 6.18 billion
CAGR (%) 14.89%

Regional Insights

The Americas represents a highly developing landscape for theranostics market development, characterized by high healthcare expenditure, robust patent registrations, and significant investments in personalized medicine. Growing awareness of personalized healthcare benefits with rising public and private sector investments for research and application in theranostics are expected to create a platform for the market in the Americas. In the European Union (EU), regulatory support, along with strong healthcare systems, promotes the growth of the theranostics market. Countries including Germany, France, and the UK are at the forefront, with research centered on oncology and neurodegenerative diseases. The Middle East shows emerging interest, propelled by investments in healthcare infrastructure and partnerships with Western biotech firms. Africa displays potential particularly in regions with developing healthcare systems, focusing on accessible diagnostic services. Asia Pacific is rapidly emerging as a significant region in the theranostics field, backed by government initiatives aimed at boosting innovation in personalized medicine. Japan's aging population drives need for advanced theranostic solutions, particularly in oncology and cardiovascular diseases. India, with its growing healthcare sector and focus on affordable care, is witnessing increased investment in localized theranostic research and collaborations.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Theranostics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing prevalence of target diseases globally
      • Rising advancements in personalized medicine and molecular biology
    • Market Restraints
      • High costs associated with R&D and the complexity of regulatory approvals
    • Market Opportunities
      • Increasing integration of data analytics and machine learning in theranostics
      • Growing development of novel biomarkers and non-invasive imaging techniques
    • Market Challenges
      • Data privacy and the ethical considerations of personalized medicine
  • Market Segmentation Analysis
    • Product: Rising usage of software for data acquisition, processing, and analysis
    • End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Theranostics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Theranostics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort

Clarity Pharmaceuticals announced the positive progression of its phase I/IIa SECuRE trial, evaluating the novel theranostic agent 64Cu/67Cu-SAR-bisPSMA in metastatic castration-resistant prostate cancer (mCRPC) patients. In the latest update, the trial's cohort 3, operating under a 3+3 study design, treated three participants with the highest dose of 12GBq of 67Cu-SAR-bisPSMA, demonstrating promising safety and efficacy outcomes. This advancement, along with continued positive outcomes, particularly under the FDA's Expanded Access Program (EAP), underscores SAR-bisPSMA's promise to improve treatment outcomes for prostate cancer patients. [Published On: 2023-11-29]

BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics

GE Healthcare and BAMF Health have collaborated to accelerate the adoption of theranostic solutions across the U.S., emphasizing the importance of innovative technologies and services to enhance patient care. By integrating GE HealthCare's comprehensive solutions and BAMF Health's expertise in molecular imaging and theranostics, this partnership is poised to establish a robust framework for the deployment of precision medicine. [Published On: 2023-11-13]

UCLA Health to Open Theranostics Center

UCLA Health is gearing up to launch its pioneering outpatient theranostics center later this year, marking a significant milestone in the treatment of advanced cancer. This state-of-the-art 3,000-square-foot facility situated on the Westwood campus's 100 Medical Plaza building is designed to optimize patient care. With eight infusion chairs, the center aims to deliver up to 80 transfusions weekly, amounting to 4,000 treatment cycles annually, primarily focusing on patients with advanced prostate cancer, neuroendocrine tumors, and thyroid cancer. [Published On: 2023-05-22]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Theranostics Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Theranostics Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Ariceum Therapeutics GmbH, Astellas Pharma Inc., BAMF Health, Bayer AG, bioMerieux SA, Biosynth Ltd., Cardinal Health, Inc., Cerebral Therapeutics, Inc., Clarity Pharmaceuticals, Curasight A/S, Curium Inc., Evergreen Theragnostics, Inc., GE HealthCare Technologies, Inc., Hermes Medical Solutions AB, Icon Group, Indi Molecular, Inc., Integrated Clinical Oncology Network Pty Ltd., Invicro, LLC, Ipsen Pharma, Radiopharm Theranostics Limited, Ratio Therapeutics, Siemens Healthineers AG, SOFIE Co., Telix Pharmaceuticals Limited, and United Theranostics.

Market Segmentation & Coverage

This research report categorizes the Theranostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Product
      • Diagnostic Imaging
        • Functional Imaging
        • Molecular Imaging
        • Nuclear Imaging
      • In Vitro Diagnostics/Biomarker Screening
        • Fluorescence In Situ Hybridization
        • Next-generation Sequencing
        • Polymerase Chain Reaction
      • Radiopharmaceuticals
        • Fluorine-18
        • Gallium-68
        • lodine-131
        • Lutetium-177
        • Radium-223
        • Samarium-153
        • Strontium-89
        • Technetium-99
        • Yttrium-90
    • Services
    • Software
      • Imaging Analytics
      • Predictive Modeling
  • Application
    • Bone Metastatis
    • Cardiovascular Diseases
    • Lymphoma
    • Neuroendocrine Tumors
    • Prostate Cancer
  • End-User
    • Cancer Care Centers
    • Hospitals
    • Research & Academic Centers
    • Theranostics Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of target diseases globally
      • 5.1.1.2. Rising advancements in personalized medicine and molecular biology
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with R&D and the complexity of regulatory approvals
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing integration of data analytics and machine learning in theranostics
      • 5.1.3.2. Growing development of novel biomarkers and non-invasive imaging techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy and the ethical considerations of personalized medicine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising usage of software for data acquisition, processing, and analysis
    • 5.2.2. End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Theranostics Market, by Product

  • 6.1. Introduction
  • 6.2. Product
  • 6.3. Services
  • 6.4. Software

7. Theranostics Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastatis
  • 7.3. Cardiovascular Diseases
  • 7.4. Lymphoma
  • 7.5. Neuroendocrine Tumors
  • 7.6. Prostate Cancer

8. Theranostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Cancer Care Centers
  • 8.3. Hospitals
  • 8.4. Research & Academic Centers
  • 8.5. Theranostics Centers

9. Americas Theranostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Theranostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Theranostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort
    • 12.3.2. BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics
    • 12.3.3. UCLA Health to Open Theranostics Center
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. THERANOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. THERANOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. THERANOSTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. THERANOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 97. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 98. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 99. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 111. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 112. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 113. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 114. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 115. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 116. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 117. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 127. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 128. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 129. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 130. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 131. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 132. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 133. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 143. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 144. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 145. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 146. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 147. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 148. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 149. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 158. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 159. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 160. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 161. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 162. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 163. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 164. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 165. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 174. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 175. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 176. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 177. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 178. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 179. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 180. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 181. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 210. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 212. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 214. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 216. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 226. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 227. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 228. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 229. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 230. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 231. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 232. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 233. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 242. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 243. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 244. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 245. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 246. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 247. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 248. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 249. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 258. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 259. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 260. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 261. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 262. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 263. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 264. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 265. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 274. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 275. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 276. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 277. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 278. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 279. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 280. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 281. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 290. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 291. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 292. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 293. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 294. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 295. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 296. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 297. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 306. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 307. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 308. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 309. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 310. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 311. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 312. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 322. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 323. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 324. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 325. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 326. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 327. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 328. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 329. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 338. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 339. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 340. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 341. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 342. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 343. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 344. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 345. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 350. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 351. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 354. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 355. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 356. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 357. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 358. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 359. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 360. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWAR